CPHI & PMEC China 2026
06/2026 – 06/2026
À Propos de l'Entreprise
- Raison sociale: ZHEJIANG JINGXIN PHARMACEUTICAL CO.LTD.
- Pays d'enregistrement: China
- Adresse: No.800, Dadao East Road,Chengguan, Zhejiang
- Année de création: 1990
Description:
Jingxin Pharm is a producer of APIs such as Simvastatin, Levofloxacin Hemihydrate, Ciprofloxacin HCl, Gatifloxacin, and Enrofloxacin Base and HCl, as well as finished dosage forms such as tablets, capsules and injections. Jingxin Pharm holds EDMF and US DMF filings for all products, and its formulation factory has received German GMP approval.
Activités Commerciales
Formes Pharmaceutiques Finies
Fabricant
Excipients & Additifs
Fabricant
Marchés de Vente
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Northern Europe: Denmark, Estonia, Finland, Iceland
Nos Produits & Services
Proofs
Évaluations
(0)
(0)
(0)
(0)
(0)
Commentaires
Filtres :
Trier par :
Aucun commentaire disponible.
Laissez votre note & commentaire